TOPDAĞI, Ö. Et Al. 2024. Can Apigenin Be an Effective Therapeutic Agent Against Experimental Renal Ischemia-Reperfusion Injury?. Pediatric Practice and Research , vol.12, no.2 , 53-56.

TOPDAĞI, Ö., GÜLER, M. C., ERASLAN, E., EKİNCİ AKDEMİR, F. N., TANYELİ, A., ÖZBEK ŞEBİN, S., ... ŞEBİN, E.(2024). Can Apigenin Be an Effective Therapeutic Agent Against Experimental Renal Ischemia-Reperfusion Injury?. Pediatric Practice and Research , vol.12, no.2, 53-56.

TOPDAĞI, ÖMER Et Al. "Can Apigenin Be an Effective Therapeutic Agent Against Experimental Renal Ischemia-Reperfusion Injury?," Pediatric Practice and Research , vol.12, no.2, 53-56, 2024

TOPDAĞI, ÖMER Et Al. "Can Apigenin Be an Effective Therapeutic Agent Against Experimental Renal Ischemia-Reperfusion Injury?." Pediatric Practice and Research , vol.12, no.2, pp.53-56, 2024

TOPDAĞI, Ö. Et Al. (2024) . "Can Apigenin Be an Effective Therapeutic Agent Against Experimental Renal Ischemia-Reperfusion Injury?." Pediatric Practice and Research , vol.12, no.2, pp.53-56.

@article{article, author={ÖMER TOPDAĞI Et Al. }, title={Can Apigenin Be an Effective Therapeutic Agent Against Experimental Renal Ischemia-Reperfusion Injury?}, journal={Pediatric Practice and Research}, year=2024, pages={53-56} }